首页 > 最新文献

Pharmaceutical Sciences Asia最新文献

英文 中文
Physical stability and subjective efficacy study of liposome loaded with Clitoria ternatea (butterfly pea) flower extract and Eugenia caryophyllus (clove) oil 阴蒂花提取物和丁香油脂质体的物理稳定性及主观药效研究
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.29090/psa.2022.01.21.077
Natchaporn Choochuen, Ampa Jimtaisong
Clitoria ternatea, commonly known as butterfly pea or blue pea, is an edible plant species belonging to the Fabaceae family. The plant has several therapeutic activities like a memory enhancer, antidepressant, antistress, sedative agent, anxiolytic and tranquilizing agent . The C. ternatea blue flower contains anthocyanins, which are mainly delphinidin-glucosides. The blue flowers of butterfly peas have good free radical scavenging activity and have potential as antioxidants. The flower is commonly used as a source of natural coloring agent for food and cosmetics and as a natural pH indicator in pharmaceutical industry. It has been reported that the butterfly pea flower fermentation solution can be added to cosmetic formula as a natural raw material of skin care products to improve moisture retention and had whitening effects. The application of crushed fresh butterfly pea flower (also known as Aunchan) directly on the eyebrows and scalp for the benefits of coloring and promoting hair growth is traditionally and commonly found in Thailand. The ability to promote hair growth may be related with its inhibition of the 5α-reductase enzyme activity. Clove (Eugenia caryophyllus) is an important medicinal plant that has been employed for centuries as food preservative and pain reliever. It is also claimed to be the rich source of phenolic antioxidants. Eugenol and eugenyl acetate, which are poorly water soluble
阴蒂(cliitoria ternatea),俗称蝶豆或蓝豆,是豆科的一种可食用植物。这种植物有多种治疗作用,如记忆增强剂、抗抑郁剂、抗压力剂、镇静剂、抗焦虑剂和安定剂。青花含有花青素,主要是飞燕草苷苷类。蝶豆蓝花具有良好的自由基清除活性,具有抗氧化潜力。它是食品和化妆品的天然着色剂来源,也是制药工业的天然pH指示剂。有报道称,蝶豆花发酵液可作为护肤品的天然原料添加到化妆品配方中,提高保湿性,具有美白效果。将压碎的新鲜蝴蝶豌豆花(也被称为蚕豆花)直接涂抹在眉毛和头皮上,以获得着色和促进头发生长的好处,这在泰国是传统和普遍的做法。促进头发生长的能力可能与其抑制5α-还原酶活性有关。丁香(Eugenia caryophyllus)是一种重要的药用植物,几个世纪以来一直被用作食品防腐剂和止痛药。它也被认为是酚类抗氧化剂的丰富来源。丁香酚和丁香酯醋酸酯,它们的水溶性很差
{"title":"Physical stability and subjective efficacy study of liposome loaded with Clitoria ternatea (butterfly pea) flower extract and Eugenia caryophyllus (clove) oil","authors":"Natchaporn Choochuen, Ampa Jimtaisong","doi":"10.29090/psa.2022.01.21.077","DOIUrl":"https://doi.org/10.29090/psa.2022.01.21.077","url":null,"abstract":"Clitoria ternatea, commonly known as butterfly pea or blue pea, is an edible plant species belonging to the Fabaceae family. The plant has several therapeutic activities like a memory enhancer, antidepressant, antistress, sedative agent, anxiolytic and tranquilizing agent . The C. ternatea blue flower contains anthocyanins, which are mainly delphinidin-glucosides. The blue flowers of butterfly peas have good free radical scavenging activity and have potential as antioxidants. The flower is commonly used as a source of natural coloring agent for food and cosmetics and as a natural pH indicator in pharmaceutical industry. It has been reported that the butterfly pea flower fermentation solution can be added to cosmetic formula as a natural raw material of skin care products to improve moisture retention and had whitening effects. The application of crushed fresh butterfly pea flower (also known as Aunchan) directly on the eyebrows and scalp for the benefits of coloring and promoting hair growth is traditionally and commonly found in Thailand. The ability to promote hair growth may be related with its inhibition of the 5α-reductase enzyme activity. Clove (Eugenia caryophyllus) is an important medicinal plant that has been employed for centuries as food preservative and pain reliever. It is also claimed to be the rich source of phenolic antioxidants. Eugenol and eugenyl acetate, which are poorly water soluble","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88295916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of genes coding for anti-HIV proteins MAP30 and MRK29 from Thai bitter melon (Momordica charantia L.) 泰国苦瓜抗hiv蛋白MAP30和MRK29基因编码的研究
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.29090/psa.2022.01.21.104
Paktraporn Mekloy, K. Sakchaisri, W. Jiratchariyakul, S. Bunsupa
Momordica charantia L. (M. charantia), also known as bitter melon, belongs to the Cucurbitaceae family. M. charantia is cultivated in many regions globally, including Asia, South America, and Africa. It has many varieties and local names, including the Chinese variety (lai-pu-tao, ku-gua), Japanese variety (goya), Indian variety (karela), Vietnamese variety (la khoqua), and Thai variety (mara). Varieties differ substantially in the shape and bitterness of the fruit. However, they have the same scientific name as Momordica charantia L.. The plant has been widely used as herbal anti-aging medicine. Major pharmacological activities that have been observed in bitter melon include abortifacient, antidiabetic, antibacterial, antiviral, and antitumor. These characteristics have been correlated with the presence of phytochemicals, including saponins, alkaloids, triterpenes, steroids, and proteins. Several compounds have been isolated from all plant parts, such as momordicins, charantins, cucurbitins, and goyaglycosides. Charantins, a mixture of steroidal saponins found in the fruits of M. charantia exhibit hypoglycaemic activity. Many proteins and peptides which possess RNA N-glycosidase, DNase-like, antitumor, immunosuppressive, and antimicrobial activities have also been isolated, such as
苦瓜(Momordica charantia L., M. charantia),又名苦瓜,属于葫芦科。夏兰草在全球许多地区都有种植,包括亚洲、南美和非洲。它有许多品种和地方名称,包括中国品种(lai-pu-tao, ku-gua),日本品种(goya),印度品种(karela),越南品种(la khoqua)和泰国品种(mara)。不同的品种在形状和苦味上有很大的不同。然而,它们与Momordica charantia L有着相同的学名。这种植物已被广泛用作抗衰老的草药。在苦瓜中观察到的主要药理作用包括堕胎、降糖、抗菌、抗病毒和抗肿瘤。这些特征与植物化学物质的存在有关,包括皂苷、生物碱、三萜、类固醇和蛋白质。一些化合物已经从所有的植物部位分离出来,如苦瓜素、香瓜素、葫芦素和山茱萸苷。Charantins是一种混合物,在charantia的果实中发现的甾体皂苷具有降血糖活性。许多具有RNA n -糖苷酶、核糖核酸样、抗肿瘤、免疫抑制和抗菌活性的蛋白质和肽也被分离出来,如
{"title":"Investigation of genes coding for anti-HIV proteins MAP30 and MRK29 from Thai bitter melon (Momordica charantia L.)","authors":"Paktraporn Mekloy, K. Sakchaisri, W. Jiratchariyakul, S. Bunsupa","doi":"10.29090/psa.2022.01.21.104","DOIUrl":"https://doi.org/10.29090/psa.2022.01.21.104","url":null,"abstract":"Momordica charantia L. (M. charantia), also known as bitter melon, belongs to the Cucurbitaceae family. M. charantia is cultivated in many regions globally, including Asia, South America, and Africa. It has many varieties and local names, including the Chinese variety (lai-pu-tao, ku-gua), Japanese variety (goya), Indian variety (karela), Vietnamese variety (la khoqua), and Thai variety (mara). Varieties differ substantially in the shape and bitterness of the fruit. However, they have the same scientific name as Momordica charantia L.. The plant has been widely used as herbal anti-aging medicine. Major pharmacological activities that have been observed in bitter melon include abortifacient, antidiabetic, antibacterial, antiviral, and antitumor. These characteristics have been correlated with the presence of phytochemicals, including saponins, alkaloids, triterpenes, steroids, and proteins. Several compounds have been isolated from all plant parts, such as momordicins, charantins, cucurbitins, and goyaglycosides. Charantins, a mixture of steroidal saponins found in the fruits of M. charantia exhibit hypoglycaemic activity. Many proteins and peptides which possess RNA N-glycosidase, DNase-like, antitumor, immunosuppressive, and antimicrobial activities have also been isolated, such as","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"45 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85680602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of weight variation and dissolution of Edoxaban split tablets in pharmacy practice 药学实践中艾多沙班片剂重量变化及溶出度的研究
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-01-01 DOI: 10.29090/psa.2022.02.21.133
M. Nimworapan, Sinwisuth Sutheechai, W. Wongcharoen, A. Phrommintikul, S. Eakanunkul
Edoxaban is available in 60 mg, 30 mg, and 15 mg unscored film-coated tablets. Tablet splitting may be an option to reduce medication costs and reduce the country’s budget. The objectives of this study were to determine the weight variation and the dissolution profile of the 60 mg edoxaban in split half-tablets using a pill splitter. Thirty edoxaban 60 mg tablets were cut into halves by a right-handed pharmacist. The weight variation of the whole and half tablets were compared. For the dissolution test, 6 whole tablets and 12 half-tablets were separately dissolved in three dissolution media. Sixty half-tablets of edoxaban had the expected half-tablet weight within the 75% to 125% range that fell within the proxy United States Pharmacopeia (USP). The mean total weight of the 1 st and 2 nd halves were not significantly different from the mean weight of the intact tablets ( p -value=0.216). The amount of drug release from the whole and half tablets in 0.1 N HCl medium was greater than 85% in 15 minutes which met the acceptance criteria for the dissolution test. Edoxaban tablets splitting had low variations in weight. Therefore, edoxaban tablets can be split into halves by a tablet cutter.
依多沙班有60mg、30mg和15mg无刻痕薄膜包衣片剂。片剂拆分可能是降低药物成本和减少国家预算的一种选择。本研究的目的是测定60 mg艾多沙班半片剂的重量变化和溶出度。30片60毫克的依多沙班被一名右撇子药剂师切成两半。比较了整片和半片的重量变化情况。溶出度试验采用3种溶出介质分别溶出6片整片和12片半片。60半片依多沙班的预期半片重量在美国药典(USP)的75% - 125%范围内。第1、2半片剂的平均总重量与完整片剂的平均总重量无显著差异(p值=0.216)。在0.1 N HCl介质中,15 min内整片和半片的释药量均大于85%,符合溶出度试验验收标准。艾多沙班片剂分裂后重量变化较小。因此,依多沙班片剂可以用片剂切割器切成两半。
{"title":"Study of weight variation and dissolution of Edoxaban split tablets in pharmacy practice","authors":"M. Nimworapan, Sinwisuth Sutheechai, W. Wongcharoen, A. Phrommintikul, S. Eakanunkul","doi":"10.29090/psa.2022.02.21.133","DOIUrl":"https://doi.org/10.29090/psa.2022.02.21.133","url":null,"abstract":"Edoxaban is available in 60 mg, 30 mg, and 15 mg unscored film-coated tablets. Tablet splitting may be an option to reduce medication costs and reduce the country’s budget. The objectives of this study were to determine the weight variation and the dissolution profile of the 60 mg edoxaban in split half-tablets using a pill splitter. Thirty edoxaban 60 mg tablets were cut into halves by a right-handed pharmacist. The weight variation of the whole and half tablets were compared. For the dissolution test, 6 whole tablets and 12 half-tablets were separately dissolved in three dissolution media. Sixty half-tablets of edoxaban had the expected half-tablet weight within the 75% to 125% range that fell within the proxy United States Pharmacopeia (USP). The mean total weight of the 1 st and 2 nd halves were not significantly different from the mean weight of the intact tablets ( p -value=0.216). The amount of drug release from the whole and half tablets in 0.1 N HCl medium was greater than 85% in 15 minutes which met the acceptance criteria for the dissolution test. Edoxaban tablets splitting had low variations in weight. Therefore, edoxaban tablets can be split into halves by a tablet cutter.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"6 2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86412580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pinostrobin attenuates colistin-induced apoptosis of human renal proximal tubular cells Pinostrobin减轻粘菌素诱导的人肾近端小管细胞凋亡
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.29090/psa.2021.06.21.008
N. Worakajit, Penjai Thongnuanjan, Napason Chabang, Sirima Soodvilai, P. Tuchinda, S. Soodvilai
1 Research Center of Transporter Protein for Medical Innovation, Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand 2 Toxicology Graduate Program, Multidisciplinary Unit, Faculty of Science, Mahidol University, Bangkok, Thailand 3 School of Bioinnovation and Bio-based Product Intelligence, Faculty of Science, Mahidol University, Bangkok, Thailand 4 Department of Pharmaceutical Technology, Faculty of Pharmacy, Rangsit University, Pathumthani, Thailand 5 Excellent Center for Drug Discovery, Mahidol University, Bangkok, Thailand
1泰国曼谷玛希隆大学理学院生理学系转运蛋白医学创新研究中心2泰国曼谷玛希隆大学理学院多学科单元毒理学研究生课程3泰国曼谷玛希隆大学理学院生物创新与生物基产品智能学院4泰国巴吞他尼朗实大学药学院制药技术系泰国5玛希隆大学优秀药物发现中心,泰国曼谷
{"title":"Pinostrobin attenuates colistin-induced apoptosis of human renal proximal tubular cells","authors":"N. Worakajit, Penjai Thongnuanjan, Napason Chabang, Sirima Soodvilai, P. Tuchinda, S. Soodvilai","doi":"10.29090/psa.2021.06.21.008","DOIUrl":"https://doi.org/10.29090/psa.2021.06.21.008","url":null,"abstract":"1 Research Center of Transporter Protein for Medical Innovation, Department of Physiology, Faculty of Science, Mahidol University, Bangkok, Thailand 2 Toxicology Graduate Program, Multidisciplinary Unit, Faculty of Science, Mahidol University, Bangkok, Thailand 3 School of Bioinnovation and Bio-based Product Intelligence, Faculty of Science, Mahidol University, Bangkok, Thailand 4 Department of Pharmaceutical Technology, Faculty of Pharmacy, Rangsit University, Pathumthani, Thailand 5 Excellent Center for Drug Discovery, Mahidol University, Bangkok, Thailand","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"19 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81422161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Natural-resin in-situ-forming gels: Physicochemical characteristics and bioactivities 天然树脂原位成型凝胶:物理化学特性和生物活性
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.29090/psa.2021.05.20.077
E. M. Khaing, Torsak Intaraphairot, Wichai Santimaleeworagu, Yaowalak Phorom, Tiraniti Chuenbarn, T. Phaechamud
1 Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 2 Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 3 Natural Bioactive and Material for Health Promotion and Drug Delivery System Group (NBM), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 4 Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 5 Office of Secretary, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand
1泰国叻空大学药学院制药技术系2泰国叻空大学药学院生物药剂学系3泰国叻空大学药学院天然生物活性物质促进健康和药物输送系统组(NBM) 4泰国叻空大学药学院药学系5秘书办公室泰国那空府,Silpakorn大学药学院
{"title":"Natural-resin in-situ-forming gels: Physicochemical characteristics and bioactivities","authors":"E. M. Khaing, Torsak Intaraphairot, Wichai Santimaleeworagu, Yaowalak Phorom, Tiraniti Chuenbarn, T. Phaechamud","doi":"10.29090/psa.2021.05.20.077","DOIUrl":"https://doi.org/10.29090/psa.2021.05.20.077","url":null,"abstract":"1 Department of Pharmaceutical Technology, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 2 Department of Biopharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 3 Natural Bioactive and Material for Health Promotion and Drug Delivery System Group (NBM), Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 4 Department of Pharmacy, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand 5 Office of Secretary, Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"29 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85099307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Medication use evaluation for Clostridium difficile infection: a case of super tertiary care hospital in northeastern Thailand 艰难梭菌感染的用药评价:泰国东北部一家超三级医院一例
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.29090/psa.2021.04.20.106
C. Soontornpas, P. Mootsikapun, Ratchadaporn Soontornpas
Clostridium difficile infection (CDI) is a common and serious nosocomial infection worldwide. It is also problem in our hospital, a medical school in Khon Kaen University. Rationale use of antimicrobial in the treatment of CDI is still being questionable. This study aimed to explore the characteristic and evaluate the treatment of CDI in our setting. This retrospective cohort study was performed in 168 CDI patients admitted at Srinagarind Hospital between October 2013 and September 2016. Patient medical records were reviewed for demographics, comorbidities, antimicrobial exposures, treatments and clinical outcomes. Antimicrobial therapy for CDI was then evaluated in accordance with the current CDI guideline. Most CDI patients aged over 50 years (72.6%) and 42.8% aged over 65 years. Common comorbidities in the patients were cardiovascular disease (47.6%), diabetes mellitus (27.4%), chronic kidney disease (20.8%), malignancy (16.7%), cerebrovascular disease (11.3%), chronic hepatitis (3.6%) and chronic obstructive pulmonary disease (2.4%). Patients who had taken antimicrobial during hospitalization prior to CDI diagnosis constituted 83.9% of total study population. Metronidazole, vancomycin and both were initial therapy in 83.9, 4.8 and 11.3% of CDI, respectively. Appropriateness of CDI treatment in all terms was 44% and recovery rate was 62% of assessable cases. Nine patients (5.4%) died during hospitalization. In conclusion, most patients had CDI risk factors including elderly, comorbidity, antimicrobial exposure, and prolonged hospital stay. Inappropriate CDI treatment was found in asymptomatic carriers or inappropriate treatment duration. Initial therapy with metronidazole should change to oral vancomycin which was the first-line therapy in the current guidelines.
艰难梭菌感染(CDI)是世界范围内常见而严重的医院感染。这也是我们医院的问题,这是孔敬大学的一所医学院。在CDI治疗中使用抗菌素的合理性仍然存在疑问。本研究旨在探讨本院CDI的特点及治疗方法。本回顾性队列研究对2013年10月至2016年9月在斯利那加林医院住院的168例CDI患者进行了研究。对患者的医疗记录进行了人口统计、合并症、抗微生物药物暴露、治疗和临床结果的审查。然后根据目前的CDI指南评估CDI的抗菌治疗。大多数CDI患者年龄超过50岁(72.6%),42.8%的患者年龄超过65岁。常见合并症为心血管疾病(47.6%)、糖尿病(27.4%)、慢性肾脏疾病(20.8%)、恶性肿瘤(16.7%)、脑血管疾病(11.3%)、慢性肝炎(3.6%)、慢性阻塞性肺疾病(2.4%)。CDI诊断前住院期间使用抗菌药物的患者占总研究人群的83.9%。甲硝唑、万古霉素及两者均为首发治疗,分别占CDI的83.9%、4.8%和11.3%。CDI治疗在所有方面的适宜性为44%,可评估病例的治愈率为62%。9例(5.4%)患者在住院期间死亡。综上所述,大多数患者存在CDI的危险因素,包括年龄、合并症、抗菌药物暴露和住院时间延长。无症状感染者CDI治疗不当或治疗时间不适宜。最初的甲硝唑治疗应改为口服万古霉素,这是目前指南中的一线治疗方法。
{"title":"Medication use evaluation for Clostridium difficile infection: a case of super tertiary care hospital in northeastern Thailand","authors":"C. Soontornpas, P. Mootsikapun, Ratchadaporn Soontornpas","doi":"10.29090/psa.2021.04.20.106","DOIUrl":"https://doi.org/10.29090/psa.2021.04.20.106","url":null,"abstract":"Clostridium difficile infection (CDI) is a common and serious nosocomial infection worldwide. It is also problem in our hospital, a medical school in Khon Kaen University. Rationale use of antimicrobial in the treatment of CDI is still being questionable. This study aimed to explore the characteristic and evaluate the treatment of CDI in our setting. This retrospective cohort study was performed in 168 CDI patients admitted at Srinagarind Hospital between October 2013 and September 2016. Patient medical records were reviewed for demographics, comorbidities, antimicrobial exposures, treatments and clinical outcomes. Antimicrobial therapy for CDI was then evaluated in accordance with the current CDI guideline. Most CDI patients aged over 50 years (72.6%) and 42.8% aged over 65 years. Common comorbidities in the patients were cardiovascular disease (47.6%), diabetes mellitus (27.4%), chronic kidney disease (20.8%), malignancy (16.7%), cerebrovascular disease (11.3%), chronic hepatitis (3.6%) and chronic obstructive pulmonary disease (2.4%). Patients who had taken antimicrobial during hospitalization prior to CDI diagnosis constituted 83.9% of total study population. Metronidazole, vancomycin and both were initial therapy in 83.9, 4.8 and 11.3% of CDI, respectively. Appropriateness of CDI treatment in all terms was 44% and recovery rate was 62% of assessable cases. Nine patients (5.4%) died during hospitalization. In conclusion, most patients had CDI risk factors including elderly, comorbidity, antimicrobial exposure, and prolonged hospital stay. Inappropriate CDI treatment was found in asymptomatic carriers or inappropriate treatment duration. Initial therapy with metronidazole should change to oral vancomycin which was the first-line therapy in the current guidelines.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"53 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77032916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of calcium - vitamin D supplementation on children with abnormal vitamin D status, low BMD, or both in Vietnam 补充钙-维生素D对越南维生素D异常、低骨密度或两者兼而有之儿童的疗效
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.29090/psa.2021.03.20.038
P. M. Nguyen, Linh V. Pham, K. Nguyen, Dat Tan Nguyen, Hanh Duong Nguyen, Nong Van Lai, B. Nguyen, Yen N Diep, Thang Nguyen
The effects of calcium and vitamin D supplementation on representative factors of bone health have been separately evaluated in different study populations worldwide, however, no data from solely one study population that comprehensively assess the supplementation outcomes on the skeletal system are available. We aimed to evaluate how calcium and vitamin D affect vitamin D level, bone mineral density (BMD), parathyroid hormone (PTH), and bone turnover markers as well as growth parameters in schoolchildren with abnormal vitamin D status and/or low BMD. An uncontrolled trial was carried out on 151 schoolchildren, aged 6-14, recruited from Can Tho City, Vietnam. The subjects were prescribed the combinations of calcium and vitamin D based on their age for a course of 6 months. After the intervention, the concentration of 25OHD was significantly improved (P < 0.001) and only 5.3% of the subjects were found to have an abnormal 25OHD level. Only 10.6%, compared with 66.89% before supplementation, had low BMD after the intervention (P < 0.05). The supplementation also increased weight and height and decreased P1NP. However, no significant changes were observed in β-CTx among boys and in PTH among the two genders. There was a negative correlation between vitamin D level and growth parameter, β-CTx. Linear regression analyses show a significant association between height, β-CTx level, and 25OHD level. In conclusion, the findings from our research provide a comprehensive assessment of various factors affected by calcium-vitamin D supplementation.
钙和维生素D补充剂对骨骼健康代表性因素的影响已经在全球不同的研究人群中分别进行了评估,然而,没有来自单一研究人群的数据可以全面评估补充剂对骨骼系统的影响。我们旨在评估钙和维生素D如何影响维生素D水平、骨密度(BMD)、甲状旁腺激素(PTH)、骨转换标志物以及维生素D异常和/或骨密度低的学童的生长参数。对从越南芹苴市招募的151名6-14岁学童进行了一项无对照试验。研究人员根据受试者的年龄给他们服用钙和维生素D的组合,疗程为6个月。干预后25OHD浓度明显改善(P < 0.001),仅有5.3%的受试者出现25OHD异常。干预后的低骨密度仅为10.6%,而补充前为66.89% (P < 0.05)。饲粮添加后体重和身高增加,P1NP降低。然而,在男孩和两种性别的甲状旁腺激素中,β-CTx没有明显变化。维生素D水平与生长参数β-CTx呈负相关。线性回归分析显示,身高、β-CTx水平和25OHD水平之间存在显著相关性。总之,我们的研究结果提供了对钙-维生素D补充剂影响的各种因素的综合评估。
{"title":"Effectiveness of calcium - vitamin D supplementation on children with abnormal vitamin D status, low BMD, or both in Vietnam","authors":"P. M. Nguyen, Linh V. Pham, K. Nguyen, Dat Tan Nguyen, Hanh Duong Nguyen, Nong Van Lai, B. Nguyen, Yen N Diep, Thang Nguyen","doi":"10.29090/psa.2021.03.20.038","DOIUrl":"https://doi.org/10.29090/psa.2021.03.20.038","url":null,"abstract":"The effects of calcium and vitamin D supplementation on representative factors of bone health have been separately evaluated in different study populations worldwide, however, no data from solely one study population that comprehensively assess the supplementation outcomes on the skeletal system are available. We aimed to evaluate how calcium and vitamin D affect vitamin D level, bone mineral density (BMD), parathyroid hormone (PTH), and bone turnover markers as well as growth parameters in schoolchildren with abnormal vitamin D status and/or low BMD. An uncontrolled trial was carried out on 151 schoolchildren, aged 6-14, recruited from Can Tho City, Vietnam. The subjects were prescribed the combinations of calcium and vitamin D based on their age for a course of 6 months. After the intervention, the concentration of 25OHD was significantly improved (P < 0.001) and only 5.3% of the subjects were found to have an abnormal 25OHD level. Only 10.6%, compared with 66.89% before supplementation, had low BMD after the intervention (P < 0.05). The supplementation also increased weight and height and decreased P1NP. However, no significant changes were observed in β-CTx among boys and in PTH among the two genders. There was a negative correlation between vitamin D level and growth parameter, β-CTx. Linear regression analyses show a significant association between height, β-CTx level, and 25OHD level. In conclusion, the findings from our research provide a comprehensive assessment of various factors affected by calcium-vitamin D supplementation.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"17 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75967261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of didactic educational intervention on improving knowledge of antibiotics use and resistance in Yogyakarta Community 教学教育干预对提高日惹社区抗生素使用和耐药性知识的影响
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.29090/psa.2021.04.20.075
S. A. Kristina, Nada Salsabila, Y. Yulianto, G. Fortwengel
Lack of knowledge regarding antibiotics use has been widely identified as a main reason for inappropriate antibiotics use which leads to antibiotic resistance phenomenon. This study aimed to evaluate the effects of pharmacist-initiated educational intervention on promoting appropriate use of antibiotics and reducing self-medication with antibiotics. A pre and post intervention study using two validated self-administered questionnaires was performed in Yogyakarta province. A-two hour session of course and case discussion was delivered as method of intervention. Pharmacy customers attended Gema Cermat program were invited conveniently to complete both of pre- and post-educational questionnaires. Descriptive presentation was conducted to show scores on questions. Knowledge scores were categorized as poor, adequate and high. Of 268 respondents, 34.22% respondents had poor level of knowledge before receiving educational intervention, but this number decreased into 12.21% after post-interventional phase. Another 28.23% respondents had adequate level of knowledge before and then elevated into 38.28% after receiving education about appropriate use of antibiotics. Pre-education, 37.43% participants had a high level of knowledge about antibiotics use and resistance, whereas after education the number became slightly higher (49.25%). A vast majority of respondents (75.24%) became more aware about appropriate antibiotics practice after receiving educational inter- vention. Overall, didactic educational intervention imposed higher knowledge and better practice regarding antibiotics use (p < 0.05). This study showed that using didactical education intervention towards antibiotics use and resistance can be an initial strategy that led to substantial improvement of appropriate antibiotics use. Further systemic interventions to educate people should be performed and evaluated in order to promote the appropriate use of antibiotics.
缺乏抗生素使用知识已被广泛认为是抗生素使用不当导致抗生素耐药现象的主要原因。本研究旨在评估药师发起的教育干预对促进合理使用抗生素和减少自我使用抗生素的效果。在日惹省使用两份有效的自我管理问卷进行干预前和干预后研究。两小时的课程和案例讨论作为干预方法。参加Gema德国项目的药房客户被方便地邀请完成教育前和教育后的问卷调查。进行了描述性陈述,以显示问题的分数。知识得分分为差、足够和高。268名受访者中,34.22%的受访者在接受教育干预前知识水平较差,干预后这一比例降至12.21%。另外28.23%的应答者在接受合理使用抗生素知识的教育后,这一比例上升至38.28%。教育前对抗生素使用及耐药知识知晓率为37.43%,教育后略高(49.25%)。绝大多数应答者(75.24%)在接受教育干预后,对适当使用抗生素的认识有所提高。总体而言,说教式教育干预提高了抗生素使用的知识和实践水平(p < 0.05)。这项研究表明,对抗生素的使用和耐药性进行说教式教育干预可以作为一项初步策略,从而大大改善抗生素的适当使用。应实施和评估进一步的系统性干预措施,以教育人们,以促进抗生素的适当使用。
{"title":"Effect of didactic educational intervention on improving knowledge of antibiotics use and resistance in Yogyakarta Community","authors":"S. A. Kristina, Nada Salsabila, Y. Yulianto, G. Fortwengel","doi":"10.29090/psa.2021.04.20.075","DOIUrl":"https://doi.org/10.29090/psa.2021.04.20.075","url":null,"abstract":"Lack of knowledge regarding antibiotics use has been widely identified as a main reason for inappropriate antibiotics use which leads to antibiotic resistance phenomenon. This study aimed to evaluate the effects of pharmacist-initiated educational intervention on promoting appropriate use of antibiotics and reducing self-medication with antibiotics. A pre and post intervention study using two validated self-administered questionnaires was performed in Yogyakarta province. A-two hour session of course and case discussion was delivered as method of intervention. Pharmacy customers attended Gema Cermat program were invited conveniently to complete both of pre- and post-educational questionnaires. Descriptive presentation was conducted to show scores on questions. Knowledge scores were categorized as poor, adequate and high. Of 268 respondents, 34.22% respondents had poor level of knowledge before receiving educational intervention, but this number decreased into 12.21% after post-interventional phase. Another 28.23% respondents had adequate level of knowledge before and then elevated into 38.28% after receiving education about appropriate use of antibiotics. Pre-education, 37.43% participants had a high level of knowledge about antibiotics use and resistance, whereas after education the number became slightly higher (49.25%). A vast majority of respondents (75.24%) became more aware about appropriate antibiotics practice after receiving educational inter- vention. Overall, didactic educational intervention imposed higher knowledge and better practice regarding antibiotics use (p < 0.05). This study showed that using didactical education intervention towards antibiotics use and resistance can be an initial strategy that led to substantial improvement of appropriate antibiotics use. Further systemic interventions to educate people should be performed and evaluated in order to promote the appropriate use of antibiotics.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"78 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87076591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Simple and rapid dipstick test for detection of dexamethasone adulteration in traditional herbal medicines 简易快速试纸法检测中草药中地塞米松掺假
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.29090/PSA.2021.02.19.148
B. Kuswandi, Arimbi S Kartika, Nia Kristiningrum, D. K. Pratoko, Indah Purnama Sary
Simple, rapid, and low-cost dipstick test has been fabricated for the detection of dexamethasone adulteration in traditional herbal medicine (Jamu) for the joint-pain killer. The dipstick test has been constructed by immobilization of FeCl3 and K3[Fe(CN)6] in cellulose acetate film as a sensing film toward dexamethasone. The sensing film changes its color from green to blue in the presence of dexamethasone. It has response time at 10 mins and good linearity in the range 0.5-75 μg/ml of dexamethasone with correlation coefficient (r) of 0.9997, with the detection limit, was 0.422 μg/ml. The dipstick tests have been successfully used for the detection of dexamethasone adulteration in jamu for the joint-pain killer, and the result demonstrated in good correlation with the UV spectrophotometry method. Thus, the dipstick test is simple, rapid, and low-cost; it can be used as an alternative method for the detection of dexamethasone adulteration in traditional herbal medicine.
建立了一种简便、快速、低成本的关节止痛中药(Jamu)中掺假地塞米松的检测方法。将FeCl3和K3[Fe(CN)6]固定在醋酸纤维素薄膜中作为地塞米松的传感膜,构建了试纸试验。在地塞米松的作用下,传感膜的颜色由绿色变为蓝色。在0.5 ~ 75 μg/ml范围内线性良好,相关系数(r)为0.9997,检出限为0.422 μg/ml。应用量尺法对关节止痛药加木中地塞米松的掺假进行了检测,结果与紫外分光光度法具有良好的相关性。因此,试纸测试简单、快速、低成本;该方法可作为传统中草药中地塞米松掺假检测的替代方法。
{"title":"Simple and rapid dipstick test for detection of dexamethasone adulteration in traditional herbal medicines","authors":"B. Kuswandi, Arimbi S Kartika, Nia Kristiningrum, D. K. Pratoko, Indah Purnama Sary","doi":"10.29090/PSA.2021.02.19.148","DOIUrl":"https://doi.org/10.29090/PSA.2021.02.19.148","url":null,"abstract":"Simple, rapid, and low-cost dipstick test has been fabricated for the detection of dexamethasone adulteration in traditional herbal medicine (Jamu) for the joint-pain killer. The dipstick test has been constructed by immobilization of FeCl3 and K3[Fe(CN)6] in cellulose acetate film as a sensing film toward dexamethasone. The sensing film changes its color from green to blue in the presence of dexamethasone. It has response time at 10 mins and good linearity in the range 0.5-75 μg/ml of dexamethasone with correlation coefficient (r) of 0.9997, with the detection limit, was 0.422 μg/ml. The dipstick tests have been successfully used for the detection of dexamethasone adulteration in jamu for the joint-pain killer, and the result demonstrated in good correlation with the UV spectrophotometry method. Thus, the dipstick test is simple, rapid, and low-cost; it can be used as an alternative method for the detection of dexamethasone adulteration in traditional herbal medicine.","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89345794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Unit cost analysis of medical service in asia: A systematic review 亚洲医疗服务单位成本分析:系统回顾
Q4 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-01-01 DOI: 10.29090/PSA.2021.02.19.034
Ragil Setia Dianingati, A. Riewpaiboon
281 articles were excluded regarding the selection criteria. Then, 51 articles were screened on the full articles. Finally 18 articles were included in this systematic review (Figure 1). Quality indicators Description 4. Has a unit cost analysis method of this study been stated? To check whether the unit cost analysis method of the study has been clearly stated or not (can be average, micro-costing, RVU, or RCC). 5. Did this study mention indirect cost allocation method? The indirect cost allocation method can be direct method, step-down method, double distribution method, and simultaneous method. 6. Was this study stated the year of the cost value? Year of cost value means what year cost had
根据入选标准排除281篇文献。然后,对51篇文章进行全文筛选。最后,本系统综述纳入了18篇文章(图1)。是否说明了本研究的单位成本分析方法?检查本研究的单位成本分析方法是否已明确说明(可以是平均成本、微观成本、RVU或RCC)。5. 本研究是否提及间接成本分摊法?间接成本分摊法有直接法、降压法、双重分配法和同时法。6. 这项研究是否说明了当年的成本价值?年成本值是指当年的成本
{"title":"Unit cost analysis of medical service in asia: A systematic review","authors":"Ragil Setia Dianingati, A. Riewpaiboon","doi":"10.29090/PSA.2021.02.19.034","DOIUrl":"https://doi.org/10.29090/PSA.2021.02.19.034","url":null,"abstract":"281 articles were excluded regarding the selection criteria. Then, 51 articles were screened on the full articles. Finally 18 articles were included in this systematic review (Figure 1). Quality indicators Description 4. Has a unit cost analysis method of this study been stated? To check whether the unit cost analysis method of the study has been clearly stated or not (can be average, micro-costing, RVU, or RCC). 5. Did this study mention indirect cost allocation method? The indirect cost allocation method can be direct method, step-down method, double distribution method, and simultaneous method. 6. Was this study stated the year of the cost value? Year of cost value means what year cost had","PeriodicalId":19761,"journal":{"name":"Pharmaceutical Sciences Asia","volume":"19 6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80594054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Pharmaceutical Sciences Asia
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1